Overestimation of the prognostic significance of SUV measurement by positron emission tomography for non-small-cell lung cancer - Reply

被引：0
|
作者：
Komaki, R [1 ]
Sasaki, R [1 ]
Allen, PK [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 27期
关键词：
D O I：
10.1200/JCO.2005.02.4638
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6800 / 6800
页数：1
相关论文
共 50 条
  • [21] Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer
    Tomita, Masaki
    Shimizu, Tetsuya
    Ayabe, Takanori
    Onitsuka, Toshio
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (03) : 244 - 247
  • [22] Role of Positron Emission Tomography in the Early Prediction of Response to Chemotherapy in Patients With Non-Small-Cell Lung Cancer
    Skoura, Evangelia
    Datseris, Ioannis E.
    Platis, Ioannis
    Oikonomopoulos, Georgios
    Syrigos, Konstantinos N.
    CLINICAL LUNG CANCER, 2012, 13 (03) : 181 - 187
  • [23] Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer
    Salminen, E
    Mac Manus, M
    ANNALS OF MEDICINE, 2001, 33 (06) : 404 - 409
  • [24] Positron emission tomography in the management of non-small cell lung cancer
    Vansteenkiste, JF
    Stroobants, SG
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (01) : 269 - +
  • [25] Positron emission tomography (PET) of non-small cell lung cancer
    Haberkorn, U
    LUNG CANCER, 2001, 34 : S115 - S121
  • [26] The role of positron emission tomography for non-small cell lung cancer
    Chang, Albert J.
    Dehdashti, Farrokh
    Bradley, Jeffrey D.
    PRACTICAL RADIATION ONCOLOGY, 2011, 1 (04) : 282 - 288
  • [27] The relationship between maximal standardized uptake value on fluorodeoxyglucose positron emission tomography and clinical prognostic factors in non-small-cell lung cancer
    Nakamura, Y
    Watanabe, S
    Kariatumari, K
    Sakasegawa, K
    Fukumori, K
    Jinnouchi, S
    Sakata, R
    LUNG CANCER, 2005, 49 : S386 - S386
  • [28] Application of novel quantitative techniques for fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer
    Wang, Duo
    Koh, Eng-Siew
    Descallar, Joseph
    Pramana, Ariyanto
    Vinod, Shalini K.
    Shon, Ivan Ho
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (04) : 349 - 358
  • [29] Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer
    Collaud, Stephane
    Lardinois, Didier
    Tischler, Verena
    Steinert, Hans C.
    Stahel, Rolf
    Weder, Walter
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2012, 41 (03) : 612 - 616
  • [30] Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography
    Scott, WJ
    Gobar, LS
    Terry, JD
    Dewan, NA
    Sunderland, JJ
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 111 (03): : 642 - 648
12345